127 related articles for article (PubMed ID: 2965015)
1. Inhibition of rat mammary carcinogenesis by an arotinoid without a polar end group (Ro 15-0778).
Bollag W; Hartmann HR
Eur J Cancer Clin Oncol; 1987 Feb; 23(2):131-5. PubMed ID: 2965015
[TBL] [Abstract][Full Text] [Related]
2. The effects of arotinoids on rat mammary carcinogenesis.
Hartmann HR; Bollag W
Cancer Chemother Pharmacol; 1985; 15(2):141-3. PubMed ID: 3926332
[TBL] [Abstract][Full Text] [Related]
3. Effect of short-term administration of N-(4-hydroxyphenyl)-all-trans-retinamide on chemically induced mammary tumors.
Silverman J; Katayama S; Radok P; Levenstein MJ; Weisburger JH
Nutr Cancer; 1983; 4(3):186-91. PubMed ID: 6221232
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic effect of the arotinoid Ro 15-0778 on chemically induced rat mammary carcinoma.
Teelmann K; Bollag W
Eur J Cancer Clin Oncol; 1988 Jul; 24(7):1205-9. PubMed ID: 3138121
[TBL] [Abstract][Full Text] [Related]
5. Enhanced inhibition of mammary carcinogenesis by combined treatment with N-(4-hydroxyphenyl)retinamide and ovariectomy.
McCormick DL; Mehta RG; Thompson CA; Dinger N; Caldwell JA; Moon RC
Cancer Res; 1982 Feb; 42(2):508-12. PubMed ID: 6459843
[TBL] [Abstract][Full Text] [Related]
6. Lack of an effect of dietary retinoids in chemical carcinogenesis of the mouse mammary gland: inverse relationship between mammary tumor cell anaplasia and retinoid efficacy.
Welsch CW; DeHoog JV; Moon RC
Carcinogenesis; 1984 Oct; 5(10):1301-4. PubMed ID: 6237806
[TBL] [Abstract][Full Text] [Related]
7. Putative metabolites derived from dietary combinations of calcium glucarate and N-(4-hydroxyphenyl)retinamide act synergistically to inhibit the induction of rat mammary tumors by 7,12-dimethylbenz[a]anthracene.
Abou-Issa HM; Duruibe VA; Minton JP; Larroya S; Dwivedi C; Webb TE
Proc Natl Acad Sci U S A; 1988 Jun; 85(12):4181-4. PubMed ID: 2967969
[TBL] [Abstract][Full Text] [Related]
8. Chemopreventive activity of a C-glucuronide analog of N-(4-hydroxyphenyl) retinamide-O-glucuronide against mammary tumor development and growth.
Abou-Issa HM; Alshafie GA; Curley RW; Wong MF; Clagett-Dame M; Repa JJ; Sikri V
Anticancer Res; 1999; 19(2A):999-1004. PubMed ID: 10368645
[TBL] [Abstract][Full Text] [Related]
9. In vivo use of N-(4-hydroxyphenyl retinamide)-0-glucuronide as a breast cancer chemopreventive agent.
Abou-Issa H; Curley RW; Panigot MJ; Wilcox KA; Webb TE
Anticancer Res; 1993; 13(5A):1431-6. PubMed ID: 8239515
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of 7,12-dimethylbenz(a)anthracene-induced tumors and DNA adduct formation in the mammary glands of female Sprague-Dawley rats by the synthetic organoselenium compound, 1,4-phenylenebis(methylene)selenocyanate.
el-Bayoumy K; Chae YH; Upadhyaya P; Meschter C; Cohen LA; Reddy BS
Cancer Res; 1992 May; 52(9):2402-7. PubMed ID: 1568209
[TBL] [Abstract][Full Text] [Related]
11. Dose response chemopreventive potential of allyl isothiocyanate against 7,12-dimethylbenz(a)anthracene induced mammary carcinogenesis in female Sprague-Dawley rats.
Rajakumar T; Pugalendhi P; Thilagavathi S
Chem Biol Interact; 2015 Apr; 231():35-43. PubMed ID: 25744308
[TBL] [Abstract][Full Text] [Related]
12. Hormone prevention of mammary carcinogenesis by norethynodrel-mestranol.
Russo IH; Frederick J; Russo J
Breast Cancer Res Treat; 1989 Oct; 14(1):43-56. PubMed ID: 2513893
[TBL] [Abstract][Full Text] [Related]
13. The anti-tumor arotinoid Ro 40-8757 protects bone marrow from the toxic effects of cyclophosphamide.
Eliason JF; Inoue T; Kubota A; Teelmann K; Horii I; Hartmann D
Int J Cancer; 1993 Sep; 55(3):492-7. PubMed ID: 8375933
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of chorionic gonadotropin on DMBA-induced mammary carcinogenesis.
Russo IH; Koszalka M; Gimotty PA; Russo J
Br J Cancer; 1990 Aug; 62(2):243-7. PubMed ID: 2117463
[TBL] [Abstract][Full Text] [Related]
15. Effect of retinyl acetate and 4-hydroxyphenylretinamide on initiation of chemically-induced mammary tumors.
Grubbs CJ; Eto I; Juliana MM; Hardin JM; Whitaker LM
Anticancer Res; 1990; 10(3):661-6. PubMed ID: 2142393
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of mammary and urinary bladder carcinogenesis by a retinoid and a maleic anhydride-divinyl ether copolymer (MVE-2).
McCormick DL; Becci PJ; Moon RC
Carcinogenesis; 1982; 3(12):1473-6. PubMed ID: 6217919
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of 7,12-dimethylbenz(a)anthracene- and N-nitrosomethylurea-induced rat mammary cancer by dietary flavonol quercetin.
Verma AK; Johnson JA; Gould MN; Tanner MA
Cancer Res; 1988 Oct; 48(20):5754-8. PubMed ID: 3139283
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the therapeutic effects of a new arotinoid, Ro 40-8757, and all-trans- and 13-cis-retinoic acids on rat breast cancer.
Teelmann K; Tsukaguchi T; Klaus M; Eliason JF
Cancer Res; 1993 May; 53(10 Suppl):2319-25. PubMed ID: 8485719
[TBL] [Abstract][Full Text] [Related]
19. The plasticizer benzyl butyl phthalate (BBP) inhibits 7,12-dimethylbenz[a]anthracene (DMBA)-induced rat mammary DNA adduct formation and tumorigenesis.
Singletary K; MacDonald C; Wallig M
Carcinogenesis; 1997 Aug; 18(8):1669-73. PubMed ID: 9276647
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of mammary tumorigenesis in nulliparous C3H mice by chronic feeding of the synthetic retinoid, N-(4-hydroxyphenyl)-retinamide.
Welsch CW; DeHoog JV; Moon RC
Carcinogenesis; 1983 Sep; 4(9):1185-7. PubMed ID: 6224605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]